IL1B and Insulin resistance: One possible mechanism is the interplay between FGF-22 and pro-inflammatory cytokines, such as interleukin-1β (IL-1β), which are known to contribute to insulin resistance, beta-cell dysfunction, and vascular inflammation in diabetes [44,45].